SCHEMBL7739077

SCHEMBL7739077

CCCCC(=O)Nc1oc(-c2ccccc2-c2ccc([N+](=O)[O-])cc2O)nc1-c1cccc(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.42
ADORA1 P30542 3/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
PPARG P37231 1/20 0.39
SMN1; SMN2 Q16637 6/20 0.39
NPSR1 Q6W5P4 3/20 0.39
HPGD P15428 2/20 0.39
USP2 O75604 1/20 0.39
TSHR P16473 1/20 0.39
MAPT P10636 4/20 0.39
THRB P10828 1/20 0.39
HPN P05981 1/20 0.38
KDM4E B2RXH2 3/20 0.37
LMNA P02545 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALDH1A1 P00352 2/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744098 0.92 FLT1 (0.40) KDRADORA1MEN1KMT2AFLT1
SCHEMBL7744083 0.92 KDR (0.47) KDRADORA1MEN1KMT2AFLT1
SCHEMBL7739075 0.90 KDR (0.42) KDRADORA1MEN1KMT2AFLT1
SCHEMBL7744055 0.90 MEN1 (0.41) MEN1KMT2APPARGSMN1; SMN2NPSR1
SCHEMBL7744794 0.89 PKM (0.43) KDRMEN1KMT2AFLT1FLT4
SCHEMBL7744673 0.89 LMNA (0.40) MEN1KMT2APPARGSMN1; SMN2NPSR1
SCHEMBL7744645 0.88 KDR (0.55) KDRFLT1FLT4PPARGSMN1; SMN2
SCHEMBL7744763 0.87 KDM4E (0.46) KDRADORA1MEN1KMT2AFLT1
SCHEMBL7746647 0.86 KDR (0.41) KDRADORA1MEN1KMT2AFLT1
SCHEMBL7744658 0.85 FLT1 (0.39) KDRADORA1MEN1KMT2AFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed